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Abstract
Programmed  1 ribosomal frameshifting is a mechanism of gene expression whereby specific signals within messenger
RNAs direct a proportion of ribosomes to shift  1 nt and continue translating in the new reading frame. Such frameshifting
normally depends on an RNA structure stimulator 3¢-adjacent to a ‘slippery’ heptanucleotide shift site sequence. Recently we
identified an unusual frameshifting mechanism in encephalomyocarditis virus, where the stimulator involves a trans-acting
virus protein. Thus, in contrast to other examples of  1 frameshifting, the efficiency of frameshifting in
encephalomyocarditis virus is best studied in the context of virus infection. Here we use metabolic labelling to analyse the
frameshifting efficiency of wild-type and mutant viruses. Confirming previous results, frameshifting depends on a
G_GUU_UUU shift site sequence and a 3¢-adjacent stem-loop structure, but is not appreciably affected by the ‘StopGo’
sequence present ~30 nt upstream. At late timepoints, frameshifting was estimated to be 46–76%efficient.
Programmed  1 ribosomal frameshifting ( 1 PRF) is uti-
lized in the expression of many viral genes and some cellular
genes [1]. Sites of  1 PRF generally comprise a ‘slippery’
sequence (at which the change in reading frame occurs) and
a 3¢-adjacent stimulatory mRNA structure [2]. In eukar-
yotes, the slippery sequence fits a consensus motif
X_XXY_YYZ, where XXX is any three identical nucleotides
(although certain exceptions occur, such as GGU); YYY rep-
resents AAA or UUU; Z represents A, C or U; and under-
scores separate zero-frame codons. The stimulatory mRNA
structure generally comprises a stem-loop or a pseudoknot
and is nearly always separated from the shift site by a
‘spacer’ region of 5–9 nt. Typical  1 PRF efficiencies fall in
the range 5–50%.
Like other members of the family Picornaviridae, encepha-
lomyocarditis virus (EMCV) has a single-stranded RNA
genome of positive polarity which also serves as an mRNA.
Translation initiation is mediated by an internal ribosome
entry site (IRES) within the 5¢ UTR. Translation of a single
long ORF produces a polyprotein that is proteolytically
cleaved, mainly by the virus-encoded 3C protease (Fig. 1a).
Separation between 2A and 2B, however, occurs co-transla-
tionally via a mechanism known as ‘StopGo’ or ‘Stop–Carry
On’ that depends critically on the amino acid motif D(V/I)
ExNPGP (where the last proline is the first amino acid
of 2B) [3, 4]. A  1 PRF site is present in EMCV just
downstream of the junction between the 2A- and 2B-encod-
ing regions of the polyprotein ORF. When PRF occurs, ribo-
somes translate the transframe fusion protein, 2B*,
comprising the N-terminal 12 amino acids of 2B together
with 117 C-terminal amino acids encoded within the  1
frame (Fig. 1a) [5]. Frameshifting in EMCV is thought to be
important both to express the 2B* protein (whose function
is currently unknown) and to downregulate expression of
the viral enzymatic proteins [5–7]. The PRF mechanism in
EMCV is atypical due to the apparent absence of an appro-
priately spaced stimulatory RNA structure, and an initial
failure to reconstitute PRF outside of the context of virus
infection [5]. Thus, in contrast to other examples of  1 fra-
meshifting which can be studied using exogeneous reporter
constructs, it was informative to assess the efficiency and
mechanism of frameshifting in the context of the virus
genome during virus infection.
Using ribosome profiling of virus-infected cells, we recently
discovered that the frameshifting efficiency in EMCV varies
over the course of infection from negligible levels [at 2 h
post infection (p.i.)] to 70% (at 8 h p.i.), and so, by diverting
the bulk of ribosomes out of the polyprotein ORF into the
2B* ORF at late timepoints, frameshifting temporally regu-
lates the expression ratio of structural and enzymatic pro-
teins [7]. In that work, we also showed that frameshifting in
EMCV is stimulated by the viral 2A protein binding to an
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RNA stem-loop separated from the shift site sequence by a
13-nt spacer (cf. 5–9 nt for canonical frameshift stimula-
tors). Thus cellular levels of viral 2A protein provide the
temporal switch. Concurrent with the ribosome profiling
analysis, we also assessed frameshifting efficiency via
metabolic labelling of viral protein products. While poten-
tially less accurate and less sensitive at early timepoints than
ribosome profiling, metabolic labelling allowed assessment
of a greater number of mutants at late timepoints, and pro-
vided an independent assessment of frameshifting efficiency
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Fig. 1. Analysis of 2A and 2B* expression in V5-tagged wild-type (WT) and mutant EMCVs. (a) Map of the ~7700 nt EMCV genome. The
5¢ and 3¢ UTRs are indicated in black and the polyprotein ORF is indicated in pale blue with subdivisions showing mature cleavage
products. The overlapping 2B* ORF is indicated in pale pink. (b) Mutations introduced to prevent PRF (SS), and StopGo-mediated co-
translational separation at the C-terminus of 2A (LV). Additional mutants were constructed with sequence encoding a V5 tag. (c–e)
Western blot analysis of virus-infected cell lysates. BHK-21 (c) or L929 (d, e) cells were infected with V5-tagged WT or mutant viruses
at m.o.i.~10 and lysates prepared at 8 h post infecton (p.i.). Anti-V5 antibodies were from rabbit (c) or mouse (d, e) along with the
appropriate secondary antibody labelled with IRDye 680. Antibodies Mu-anti-2A, anti-2B*(N-term) and anti-2B*(C-term) were used with
the appropriate secondary antibody labelled with IRDye 800. Left and right panels show scans from, respectively, the 700 and 800 nm
channel of images obtained with a LiCor Odyssey scanner. Different markers were used for (c) and (d, e) with some differences
between the two. (f) Schematic summary of 2A-, 2B- and 2B*-related products for WT and mutant EMCVs.
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in the context of virus infection. Here we present the results
of the metabolic labelling experiments which could not be
accommodated within [7]. Confirming previous results, we
show that frameshifting depends on the G_GUU_UUU
shift site sequence and the 3¢-adjacent stem-loop structure.
We also show that frameshifting is not appreciably affected
by the ‘StopGo’ sequence present just upstream of the
frameshift site.
We used previously generated wild-type (WT), SS and LV-
WT mutant viruses (Fig. 1b) [7] which were based on the
EMCV subtype mengovirus cDNA, pMC0 of [8]. In the SS
mutant, the WT frameshift site G_GUU_UUU is mutated
to A_GUG_UUU. These mutations do not alter the poly-
protein amino acid sequence but are expected to inhibit
PRF. The LV-WT mutant, in which the shift site is WT but
StopGo is inhibited by mutating the NPGP sequence to
NPLV, was used to assess whether StopGo affects PRF. We
also generated tagged versions of these viruses (V5-WT,
V5-SS, LV-V5-WT), in which a sequence encoding a V5 tag
and glycine-serine linker (GKPIPNPLLGLDSTGSGSGS
encoded by GGC AAG CCT ATC CCT AAC CCT CTC
TTG GGA CTC GAT TCT ACA GGA TCT GGC TCC
GGC AGC) was inserted directly after the final proline
codon of the StopGo sequence. Finally, we generated a
tagged virus with both StopGo and the shift site mutated
(LV-V5-SS). Cells were transfected with T7 transcripts and
virus recovered as described previously [7]. All viruses were
able to replicate in cell culture.
To confirm inhibition of PRF by the SS mutations and inhi-
bition of StopGo co-translational separation by the LV
mutations, we performed Western blot analysis of 2A and
2B* expression in the V5-tagged viruses using polyclonal
rabbit antibodies anti-2B*(N-term) and anti-2B*(C-term),
raised against the N-terminal 12 aa shared by 2B and 2B*
and the C-terminal 14 aa of 2B*, respectively, and mouse
monoclonal antibody Mu-anti-2A, raised against the 2A
peptide HKRIRPFRLP. BHK-21 or L929 cells were infected
with V5-tagged WT or mutant viruses at m.o.i.~10 and
lysates were prepared at 8 h p.i.
Mu-anti-2A detected a product migrating just above 15 kDa
for V5-WT and V5-SS viruses (Fig. 1c, right, lanes 1–2).
This product is presumably 2A (16.7 kDa) and, as expected,
it did not react with any of the other antibodies. For LV-V5-
WT virus, inhibition of StopGo is expected to fuse 2A to
downstream products. Mu-anti-2A detected two products,
migrating at ~20 and ~34 kDa (Fig. 1c, right, lane 3). Both
products were also detected by anti-V5 (Fig. 1c, left, lane 3)
and anti-2B*(N-term) (Fig. 1d, right, lane 3). The ~34 kDa
product was not detected for LV-V5-SS virus (Fig. 1c, d,
lane 4) indicating that it is a frameshift product, presumably
V5-tagged 2A-2B* (32.8 kDa). The ~20 kDa product was
detected for both LV-V5-WT and LV-V5-SS viruses, indi-
cating that it is a zero-frame product. Consistent with this,
only the ~34 kDa product was detected with anti-2B*(C-
term) (Fig. 1e, right, lane 3). The ~20 kDa product is too
small to be V5-tagged 2A-2B (35.1 kDa), and is presumed to
result from proteolytic cleavage by the virus 3C protease
between phylogenetically conserved Q and G residues just
three amino acids downstream of the shift site, giving rise to
2A fused to the V5-tagged N-terminal 15 amino acids of 2B
(20.5 kDa; referred to here as 2A-V5-2BN) [4, 6, 9]. The ~20
and ~34 kDa products were also detected for viruses with an
intact StopGo sequence, but at a much lower level (Fig. 1c,
d, lane 1). These products arise because StopGo-mediated
co-translational separation of 2A and 2B/2B* is not 100%
efficient. Anti-2B*(C-term) also detected a product, migrat-
ing at ~19 kDa for WT-V5 virus (Fig. 1e, right, lane 1). This
product was not detected for the shift site (SS) or StopGo
(LV) mutant viruses and is presumably V5-tagged 2B*
(16.0 kDa). The product is also detected, for WT-V5 virus,
by anti-2B*(N-term) and anti-V5 (Fig. 1d, lane 1). V5-
tagged 2B (18.3 kDa) was not reliably detected with anti-V5
or anti-2B*(N-term) (which should recognize the N-termi-
nal 12 aa common to both 2B and 2B*). We also failed to
observe V5-tagged 2A-2B (35.1 kDa) in the StopGo (LV)
mutants. The failure to observe full-length 2B or 2A-2B sug-
gests that 2B may be efficiently cleaved at the aforemen-
tioned 3C cleavage site (producing 2B¢ in Fig. 1f). Note
however that neither 2B nor 2B¢ were reliably identified by
radiolabelling (below), perhaps due to co-migration with
other products. A product migrating at ~29 kDa, detected
with Mu-anti-2A, anti-V5 and anti-2B*(N-term) but not
anti-2B*(C-term), for LV-V5-WT virus only, likely repre-
sents a C-terminally truncated version of 2A-V5-2B*,
potentially arising from proteolytic cleavage within 2B*.
To calculate PRF efficiences in the context of virus infection,
L929 cells were infected at an m.o.i. of ~10 and translation
products were radiolabelled from 9 to 10 h p.i. with [35S]
methionine, separated by 6–15% SDS-PAGE (Fig. 2a), and
radioactivity in virus-specific products was quantified by
phosphorimager as described previously [7]. EMCV infec-
tion results in efficient shut-off of host cell protein synthesis
via inhibition by the viral L and 2A proteins of active nucle-
ocytoplasmic trafficking and cap-dependent translation [10,
11]; thus most well-expressed radiolabelled products corre-
spond to virus proteins. The intensity for each WT virus
product was measured, normalized by methionine content,
and then by the mean value for VP0, VP3 and VP1 to con-
trol for lane loading. Next, to factor out differences in
protein turnover besides unquantified processing intermedi-
ates, for each biological replicate the WT values for VP0,
VP3, VP1, 2C, 3A + 3AB, 3C + 3CD and 3D + 3CD were
normalized by corresponding values for SS mutant virus
(Fig. 2b). Then the normalized values for 2C, 3A + 3AB,
3C + 3CD and 3D + 3CD (i.e. products encoded down-
stream of the frameshift site) were averaged and divided by
the average of the values for VP0, VP3 and VP1 (i.e. prod-
ucts encoded upstream of the frameshift site). This gives an
estimate of the fraction of ribosomes that escape a  1 PRF
(Fig. 2c); one minus this value estimates the PRF efficiency.
The calculation uses the most easily measurable discrete
virus protein bands while some unprocessed or partially
processed polyprotein products were ignored, though
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normalization by the SS mutant is expected to largely cor-
rect for these omissions. We repeated this procedure also
for the LV-WT mutant and the V5-tagged viruses. The
mean PRF efficiencies calculated for WT, LV-WT, V5-WT
and LV-V5-WT viruses were in the range 46–63% while
V5-SS and LV-V5-SS had protein expression patterns simi-
lar to SS (Fig. 2c).
In previous work, a downstream stem-loop structure, sepa-
rated from the frameshift site by a 13-nt ‘spacer’, was identi-
fied bioinformatically and confirmed experimentally [5, 7].
This positioning is inconsistent with canonical mRNA
structure stimulators of  1 PRF, which are separated from
the shift site by just 5–9 nt. To assess the PRF-stimulatory
role of the stem-loop in the context of the virus genome
during infection, we made several new mutant EMCVs. In
SL5¢ we altered the 5¢ arm of the stem; in SL3¢ we altered
the 3¢ arm of the stem; and in SL5¢3¢ we combined both
mutations to restore the predicted RNA structure (Fig. 3a).
These mutations are non-synonymous with regards to the
2B and 2B* amino acid sequences, but are present in some
natural EMCV isolates (e.g. GenBank accession KC310737)
and, indeed, all three viruses were found to replicate in cell
culture. We also prepared another set of SL mutants (SL5¢a,
SL3¢a, SL5¢3¢a; Fig. 3a) with an additional base-pair change.
To rule out possible effects of the amino acid changes in 2B*
influencing virus replication, all stem-loop mutations were
generated in the context of a parent virus, WT-PTC, in
which two premature termination codons (PTCs) were
introduced into the 2B* reading frame without affecting the
polyprotein amino acid sequence (Fig. 3a).
The effect of these mutations on PRF was assessed by meta-
bolic labelling (Fig. 3b, lanes 10–16). Mutants in which the
stem-loop was disrupted (SL5¢, SL3¢, SL5¢a, SL3¢a) displayed
a pattern of virus protein expression similar to that of SS
mutant virus, while the stem-loop restoration mutants
(SL5¢3¢ and SL5¢3¢a) displayed a pattern of virus protein
expression similar to that of WT and WT-PTC viruses. PRF
efficiencies were estimated as above based on the ratio of
expression of products encoded downstream and upstream
of the shift site, normalized by SS mutant virus. The ratio of
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downstream to upstream products for the SL mutants
was substantially greater than for WT virus, indicating
significant, but probably not complete, disruption of PRF
(Fig. 3c).
We also constructed StopGo-inhibited (LV mutant) ver-
sions of all the SL mutant EMCVs so that we could directly
observe the PRF product 2A-2B*(PTC) [where ‘2B*(PTC)’
represents the C-terminally truncated 2B* as a result of the
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PTC mutation in the parent]. 2B*(PTC) itself (3.2 kDa) was
too small to see by SDS-PAGE, but when fused to 2A
(19.9 kDa total) it could be visualized. The LV viruses
(Fig. 3b, lanes 17–23) had ratios of downstream to upstream
products similar to the corresponding non-LV viruses
(Fig. 3c). Moreover, 2A-2B*(PTC) was only apparent in
WT-PTC and the stem-loop restoration mutants, SL5¢3¢
and SL5¢3¢a (Fig. 3b, lanes 17, 20, 23). For these three
viruses, PRF efficiencies were also estimated by quantifying
the radioactivity in 2A-2B*(PTC) (frameshift product) and
2A-2BN (i.e. 2A fused to the N-terminus of 2B), normalizing
by methionine content, and taking the ratio [2A-2B*
(PTC)]/([2A-2BN]+[2A-2B*(PTC)]). This calculation
assumes 100%-efficient cleavage of 2A-2B in the LV
mutants at the Q|G 3C-protease cleavage site near the N-
terminus of 2B (2B residues 15–16) as supported by West-
ern analysis (Fig. 1). Using this method, the PRF efficiencies
for these three viruses had values in the range 54–63%
(Fig. 3d).
Previously we tested WT and five mutants (SS, WT-SL, SS-
SL, LV-WT and LV-SS-SL; where SL indicates three synon-
ymous mutations within the stem-loop) in the context of
the full-length viral genome during virus infection using
ribosome profiling [7]. Here we test WT and a total of 20
virus mutants by metabolic labelling, of which only SS and
LV-WT overlap with the previously tested mutants. The
mean PRF efficiencies for WT, V5-WT, LV-WT, LV-V5-
WT, WT-PTC, SL5¢3¢, SL5¢3¢a, LV-WT-PTC, LV-SL5¢3¢
and LV-SL5¢3¢a fall in the range 46–76% (64±9%, mean
±SD), while direct measurement of 2A-2B*(PTC) in the lat-
ter three gave values 63, 57 and 54%. These values support
efficient frameshifting at 9–10 h p.i. but are consistently
lower than those measured previously using ribosome pro-
filing (69 , 70 and 62% at 8 h p.i. for, respectively, two WT
biological repeats and LV-WT) [7]. The ribosome profiling
analysis is expected to be significantly more accurate. Inter-
estingly, measurements in the related Theiler’s murine
encephalomyelitis virus (TMEV) using radiolabelling put
the TMEV PRF efficiency at 74–82% at 6–7 h p.i. [6].
Despite the modest discrepancy in the absolute level of late
timepoint frameshifting, the current results show that fra-
meshifting in EMCV does not depend on the StopGo
sequence (cf. WT with LV-WT; Fig. 2c) but does depend on
the stem-loop structure (cf. parent, SL5¢3¢ and SL5¢3¢a with
SL5¢, SL3¢, SL5¢a and SL3¢a; Fig. 3c), thus supporting the
results of [7] with a larger number of mutants in the context
of the virus genome during infection. The results are also
consistent with a mutational analysis of the stem-loop in
cell-free translation systems (rabbit reticulocyte lysate and
wheat germ extract), where frameshifting could be recapitu-
lated to a level of ~20% (instead of the ~70% seen in virus-
infected cells) upon addition of recombinant 2A [7].
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